Our Solutions

Newsletters

NEWSLETTERS

  • Newsletter

    March 2019

    Mar 29, 2019

    Bold new look, how to overcome bioanalytical challenges, and case studies on hybrid medicines, 505(b)(2), and drug interactions

  • Newsletter

    September 2018

    Sep 1, 2018

    Get the Scoop – A case study evaluating the abuse potential of Mirogabalin, news on our upcoming acquisition, the top trends influencing the CRO industry, and more!

  • Newsletter

    April 2018

    Apr 30, 2018

    Get the Scoop – A case study on cannabis, our latest assay list, and much more!

  • Newsletter

    January 2018

    Jan 29, 2018

    GET THE SCOOP — Up Close and Personal with our CEO and 5 Ways to Save Money on Outsourcing

  • Newsletter

    June 2017

    Jun 2, 2017

    Guideline on Equivalence Studies, Metabolic Disorders and your chance to ask our experts questions directly about hot topics like Biotherapeutics and Therapeutic Equivalence.

  • Newsletter

    February 2017

    Feb 24, 2017

    Learn about our cannabis study, biosimilars, our diabetes case studies, and so much more!

  • Newsletter

    December 2016

    Dec 15, 2016

    On December 2nd, the FDA published a guidance intended to assist applicants in preparing the clinical pharmacology section of prescription drug labeling.

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.